Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2026) 117 P299 | DOI: 10.1530/endoabs.117.P299

SFEBES2026 Poster Presentations Late Breaking (54 abstracts)

Personalised Sick-Day Care Plan in Addison’s Disease: Improving Self-Management in a Patient with Functional Dissociative Seizures

Aldons Carlo Chua , Elisabeth Ng , Rebecca Gorrigan & William Drake


St Bartholomew’s Hospital, London, United Kingdom


Background: Addison’s disease necessitates lifelong glucocorticoid replacement and proactive stress-dose management to prevent adrenal crises. Self-management becomes challenging when comorbid functional neurological disorders mimic crisis symptoms such as loss of consciousness, nausea and light headedness and weakness, leading to diagnostic confusion, frequent hospitalisations and diminished patient confidence.

Case: A 34-year-old male with Addison’s disease, postural orthostatic tachycardia syndrome, autism spectrum disorder, and learning difficulties, experienced recurrent functional dissociative seizures confirmed by video electroencephalography. Despite optimised hydrocortisone replacement (Hydrocortisone 10mg in AM, 5mg midday, 5mg PM and Fludrocortisone 100 mg BD) with reassuring day curves and biochemistry, he had recurrent admissions (7/month over one year), receiving parenteral hydrocortisone each time. Episodes featured light-headedness, weakness and collapse lasting up to 45 minutes. Recurrent episodes generated profound anxiety about distinguishing seizures from true adrenal crises.

Intervention: The endocrine team developed a personalised “traffic-light” sick-day protocol:Green: episodes <10 minutes, feeling well — no hydrocortisone adjustment. Amber: episodes >10 minutes or mild systemic symptoms (nausea, lethargy, hypotension) - take 10 mg oral hydrocortisone, increase fluids, monitor. Red: seizures >10 minutes or definite crisis features (persistent vomiting, systolic blood pressure (BP) <90 mmHg or diastolic BP < 50 mmHg) — 100 mg intramuscular hydrocortisone and seek emergency care. Implementation was supported by regular nurse-led follow-ups to reinforce education and protocol adherence.

Outcomes: Acute admissions decreased from ~84 to one annually. The patient demonstrated improved discrimination between dissociative seizures and adrenal crises, with reduced anxiety, enhanced symptom recognition, and increased confidence in self-management.

Conclusion: Personalised ‘sick-day’ protocols effectively enhance self-management in Addison’s disease complicated by overlapping functional comorbidities. This structured approach, supported by continuous education, substantially reduces unnecessary emergency care utilisation while empowering patients and improving overall quality of life. This model may benefit similar complex cases.

Volume 117

Society for Endocrinology BES 2026

Harrogate, United Kingdom
02 Mar 2026 - 04 Mar 2026

Society for Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches